Julie Smith

Ms. Julie A. Smith is a Chief Executive Officer & Director at Juvena Therapeutics, Inc., an Independent Director at Stoke Therapeutics, Inc. and an Independent Director at Exelixis, Inc. She is on the Board of Directors at Juvena Therapeutics, Inc., Stoke Therapeutics, Inc. and Exelixis, Inc. Ms. Smith was previously employed as a Chief Executive Officer & Director by Nuvig Therapeutics, Inc., a President, Chief Executive Officer & Director by ESCAPE Bio, Inc., a President, Chief Executive Officer & Director by Nuredis, Inc., an Independent Director by Audentes Therapeutics, Inc., a President & Chief Executive Officer by Raptor Pharmaceuticals, Inc., a President & Chief Executive Officer by Horizon Pharmaceutical LLC, a Chief Commercial Officer & Vice President by Enobia Pharma, Inc., a Vice President-Commercial by Jazz Pharmaceuticals, Inc., a Vice President-Global Marketing by Genzyme General, a Head-Operations & Business Development by Novazyme Pharmaceuticals, Inc., a Product Manager by Bristol Myers Squibb Co., and a Director-Health & Emerging Companies Sections by Biotechnology Innovation Organization.
She received her undergraduate degree from Cornell University.